JESSICA KUYKENDALL: Open Payments
NPI 1811654437 · DECATUR, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$594 in 41 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $361 · 2025 $594
Food & beverage: $594
| Company | Payments | Amount |
|---|---|---|
| Sage Therapeutics, LLC | 10 | $148 |
| MAYNE PHARMA COMMERCIAL LLC | 15 | $104 |
| SHIELD THERAPEUTICS INC | 4 | $72 |
| Boston Scientific Corporation | 2 | $70 |
| Astellas Pharma US Inc | 3 | $63 |
| Sumitomo Pharma America, Inc. | 2 | $42 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $36 |
| Exact Sciences Corporation | 1 | $23 |
| MILLICENT US INC | 1 | $21 |
| CooperSurgical, Inc. | 1 | $16 |
Products named: ZURZUVAE, ACCRUFER, Veozah, GEMTESA, Solyx SIS System, Bulkamid - Bulkamid Urethral Bulking Pack 2mL (OUS), The Cologuard Plus Collection Kit, INTRAROSA.
Industry payments across AL — which companies pay providers there.
